๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Xuzhou
Clinical trial register · China

Clinical Trials in Xuzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Xuzhou 8
Narrow the registerReset
Recruitment status
Phase
Site location
Xuzhou8
All 1 locations
Target enrolment
to

Trials with a site in Xuzhou

8 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia
NCT07370064AML (Acute Myeloid Leukemia)
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2026-01-31
Not yet open
Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT
NCT06963866Multiple Myeloma, Newly Diagnosed
Xuzhou Medical University
Phase 2
60
Xuzhou
2025-05-01
Recruiting
Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)
NCT06759181Multiple Myeloma
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2024-12-31
Active, closed
Multi-omics Profiling of Patients With Aplastic Anemia Before and After CD7-CAR-T Therapy
NCT07139600Aplastic Anaemia, CAR-T, CD7 Positive
Xuzhou Medical University
Observational
5
Xuzhou
2024-08-01
Recruiting
Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD
NCT06244628cGVHD
Xuzhou Medical University
Phase 3
20
Xuzhou
2024-01-10
Recruiting
Safety and Efficacy of Anti-FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)
NCT06196255Multiple Myeloma
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2023-12-25
Recruiting
Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma
NCT06132711Multiple Myeloma
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2023-11-10
Recruiting
Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)
NCT06125652Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2023-11-04
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/xuzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Xuzhou that also match the filters currently applied.

How many clinical trials are recruiting in Xuzhou?

5 of the 8 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xuzhou), 8 studies
PhaseStudiesRecruitingShare
Phase 1/25462.5%
Observational1012.5%
Phase 21012.5%
Phase 31112.5%

Most active sponsors

Lead sponsors with the most studies (Xuzhou)
Lead sponsorStudiesRecruiting
Xuzhou Medical University85
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.